<DOC>
	<DOCNO>NCT00003692</DOCNO>
	<brief_summary>RATIONALE : Video-assisted surgery may effective treatment few side effect conventional surgery patient non-small cell lung cancer . PURPOSE : Phase II trial study effectiveness video-assisted surgery treat patient non-small cell lung cancer .</brief_summary>
	<brief_title>Video-Assisted Surgery Treating Patients With Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility perform video-assisted thoracic surgery ( VATS ) lobectomy , without significant morbidity perioperative mortality , patient small ( great 3.0 cm ) , peripheral , non-small cell lung cancer . II . Determine rate thoracotomy must carry complete VATS lobectomy patient . III . Describe complication associated procedure . IV . Describe length operative procedure , duration chest tube stay , length hospitalization patient population . V. Describe survival failure-free survival , 5-year period , patient population follow procedure . OUTLINE : Patients undergo video-assisted thoracic surgery ( VATS ) lobectomy , require 3 small incision side chest . The entire anatomic pulmonary lobe remove , well peribronchial lymph node anterior hilar lymph node . If possible remove lobe use VATS approach , 1 incision convert standard thoracotomy . Patients follow every 4 month first 2 year , every 6 month next 3 year . PROJECTED ACCRUAL : A total 135 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Suspected histologically document nonsmall cell lung cancer Solitary , peripheral lung lesion great 3.0 cm No metastatic disease No positive lymph node mediastinoscopy At least 5 year since diagnosis nonsmall cell small cell lung cancer PATIENT CHARACTERISTICS : Age : Not specify Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Pulmonary : FEV1 least 1.0 L least 50 % predict Other : No significant comorbid medical psychiatric condition No active malignancy nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>occult non-small cell lung cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage 0 non-small cell lung cancer</keyword>
</DOC>